MarketCap
Facebook
X
TelegramAnnual report 2024
added 04-11-2026
So-Young International Total Assets 2011-2026 | SY
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets So-Young International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.74 B | 3.21 B | 3.2 B | 3.33 B | 3.29 B | 3.23 B | 1.34 B | 568 M | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.33 B | 568 M | 2.61 B |
Quarterly Total Assets So-Young International
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 3.33 B | - | - | - | 3.29 B | - | - | - | 3.23 B | - | - | - | 1.34 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.33 B | 1.34 B | 2.8 B |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
476 M | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | USA |
 |
HealthEquity
HQY
|
3.38 B | $ 86.33 | 0.34 % | $ 7.44 B | USA |
 |
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
1.82 B | $ 2.93 | 3.17 % | $ 275 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | USA |
 |
GoodRx Holdings
GDRX
|
1.39 B | $ 2.37 | 4.41 % | $ 914 M | USA |
 |
Akerna Corp.
KERN
|
1.25 B | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
87.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | USA |
 |
Health Catalyst
HCAT
|
503 M | $ 1.26 | -4.55 % | $ 88.1 M | USA |
 |
OptimizeRx Corporation
OPRX
|
183 M | $ 7.2 | 0.42 % | $ 123 M | USA |
 |
Premier
PINC
|
3.1 B | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
726 M | $ 12.8 | 3.73 % | $ 940 M | USA |
 |
Phreesia
PHR
|
664 M | $ 9.43 | 2.84 % | $ 563 M | USA |
 |
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
2.86 B | $ 6.1 | 7.21 % | $ 1.07 B | USA |
 |
10x Genomics
TXG
|
965 M | $ 24.59 | -5.71 % | $ 2.88 B | USA |
 |
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
7.9 M | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
324 M | $ 6.61 | 8.01 % | $ 106 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
511 M | $ 21.34 | -1.79 % | $ 648 M | USA |
 |
Omnicell
OMCL
|
2.12 B | $ 37.8 | -1.25 % | $ 1.74 B | USA |
 |
Progyny
PGNY
|
607 M | $ 18.64 | 2.87 % | $ 1.6 B | USA |
 |
Veeva Systems
VEEV
|
8.98 B | $ 168.84 | 0.53 % | $ 27.6 B | USA |
 |
Zhongchao
ZCMD
|
24.1 M | $ 2.06 | - | $ 7.04 M |  China |